Retrospective Observational Study of Acute Subdural Hematoma Treated with Idarucizumab in Japan - Retrospective Observational Study of Acute Subdural Hematoma Treated with Idarucizumab in Japan

The frequency of decreased consciousness level during the course was 30.4%. Among them, the frequency of decreased consciousness level was 14.3% in cases in which the reversal agent was administered early before deterioration of consciousness level and imaging findings was observed. Three patients (13.1%) had ischemic complications. The timing of onset of ischemic complications was 7 days or more after the administration of the reversal agent and before the resumption of anticoagulant in all patients.